• Grey LinkedIn Icon
  • Twitter

 About          Professionals          Locations

Contact Us          Careers          Disclaimer

© 2019 Alloush LLP

ATTORNEY ADVERTISING: Prior outcomes are no guarantee of future performance

Biotechnology & Pharmacuetical 

 

We represent pharmaceutical, biotechnology and medical device companies across all aspects of their businesses. We counsel on formation considerations, transactions, regulation, FDA compliance, intellectual property, finance and other matters. 

We work with emerging and established biotechnology and pharmaceutical companies in the United States and abroad in a variety of areas:  

  • Choice of entity, corporate formation and structure, corporate governance and public reporting.

  • Raising capital, including venture capital, private/preferred stock investments, debt financings, IPOs and subsequent equity follow-on financings.

  • Due diligence, mergers and acquisitions.

  • Corporate partnering, complex licensing, strategic alliances, regulatory and compliance, technology agreements, R&D collaborations, commercialization agreements, joint marketing agreements, joint ventures and supply and distribution agreements.

 

Emerging Companies

Our experience benefits all biotechnology and healthcare technology companies, regardless of size or stage of development, and in a range of matters, including:

  • Venture capital/strategic corporate financings, representing growth-stage biotechnology companies, venture capital funds and strategic corporate investors.

  • General corporate, including corporate formation, capitalization structures and negotiation of key contracts with vendors, suppliers, lenders and employees.

  • Intellectual property, including copyright, and trademark licensing, IP development agreements, infringement issues, and complex IP transactions.

  • Corporate governance covering state corporation law, SEC compliance, state and federal disclosure, regulatory requirements, and shareholder communication.

  • Joint ventures, including formation, capitalization, governance, operation and sale.

  • Mergers and acquisitions, representing both buyers and sellers in public and private transactions.

  • Executive compensation, including equity plans, bonus plans, employee benefits and other compensation matters.